Skip to content
BIOEMTECH logo — Embrace scientists translate ideas into outcomes

BIOEMTECH

Embrace scientists translate ideas into outcomes

Founded 2013 Greece Greece 36 employees Seed Total: $400.00K

General Information

Company Name BIOEMTECH
Founded Year 2013
Location Greece Greece
Employees 36
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with BIOEMTECH. To contact BIOEMTECH, visit bioemtech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BIOEMTECH compare?

A PDF of BIOEMTECH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BIOEMTECH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BIOEMTECH

BIOEMTECH is a preclinical CRO based in Greece. Established in 2013, the company's mission is to facilitate the transition from ex vivo studies to in vivo molecular imaging by offering cost-effective solutions in terms of instrumentation and services. Their flagship product, the "eyes," represents the first desktop cameras capable of real-time imaging of PET and SPECT isotopes in mice. In addition to this groundbreaking technology, BIOEMTECH conducts comprehensive studies for assessing new compounds in their authorized laboratories, equipped with advanced facilities for in vivo imaging with microPET/SPECT/CT and optical imaging, radiochemistry, and in vitro analysis. Their client base includes universities and pharmaceutical companies, and the company holds accreditations for performing toxicological studies and handling radioisotopes for evaluating diagnostic and therapeutic radiopharmaceuticals.

Notably, the company has been actively involved in numerous projects including H2020, FET, ERA, ITN, and others. This commitment to collaboration and innovation has attracted a €400.00K Seed Round investment from Metavallon VC in 23 August 2019, underscoring the potential and promise of BIOEMTECH's pioneering approach to preclinical research and molecular imaging.

Business keywords: BIOEMTECH, medical imaging systems, PET imaging, SPECT imaging, CRO, animal facility, in vitro lab, radiochemistry lab, microPET, CT imaging, optical imaging, pharmacokinetics, radiopharmaceuticals, nanomedicine, nuclear medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €400.00K 1
Metavallon VC
23 Aug 2019

BIOEMTECH Alternatives & Competitors

View All Alternatives
BIOEMTECH vs

Connecting your experiences and emotions throughout your journey.

6 employees
Manufacturing, Pharmaceutical
BIOEMTECH vs

Providing trusted quality and reliability in diagnostic imaging agents for improved patient manageme...

411 employees
Pharmaceutical
BIOEMTECH vs

Harnessing the power of radiotherapeutics for innovative cancer treatment solutions.

Series B
11-50 employees
Biotechnology

FAQ About BIOEMTECH

Embrace scientists translate ideas into outcomes
BIOEMTECH was founded in 2013.
BIOEMTECH is headquartered in Greece.
BIOEMTECH has approximately 36 employees.
BIOEMTECH has completed 1 funding round, raising a total of $400.00K. The latest funding stage is Seed.
Top alternatives and competitors to BIOEMTECH include Monrol Nuclear Products Co., PharmaLogic Holdings Corp., Alpha9 Theranostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOEMTECH and Monrol Nuclear Products Co. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BIOEMTECH, https://bouncewatch.com/company/bioemtech, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout